Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Vaccination in Oncologic Patients: A Prospective, Explorative Study

NCT04918888 is registered in ClinicalTrials.gov with Krankenhaus Barmherzige Schwestern Linz as lead sponsor.

NCT NCT04918888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04918888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Vaccination in Oncologic Patients: A Prospective, Explorative Study
Lead sponsor
Krankenhaus Barmherzige Schwestern Linz
Phase
Observational
Overall status
Completed
Start date
April 19, 2021
Completion date
September 30, 2021
Enrollment
1,150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, oncologic disorders